Publication at Faculty of Medicine in Hradec Králové |
2007
Abstract
In this work the in vitro and in vivo effects of new iron chelating compounds (namely the aroylhydrazones) were summarized and analyzed with regard on their potential to afford significant cardioprotection against anthracycline cardiotoxicity.